Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial

Title:	Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial
Authors:	Tsiakos, Konstantinos^Aff1; Tsakiris, Antonios^Aff2; Tsibris, Georgios^Aff2; Voutsinas, Pantazis-Michael^Aff2; Panagopoulos, Periklis^Aff3; Kosmidou, Maria^Aff4; Petrakis, Vasileios^Aff3; Gravvani, Areti^Aff1; Gkavogianni, Theologia^Aff2; Klouras, Eleftherios^Aff4; Katrini, Konstantina^Aff2; Koufargyris, Panagiotis^Aff2; Rapti, Iro^Aff4; Karageorgos, Athanassios^Aff2; Vrentzos, Emmanouil^Aff2; Damoulari, Christina^Aff2; Zarkada, Vagia^Aff2; Sidiropoulou, Chrysanthi^Aff5; Artemi, Sofia^Aff2; Ioannidis, Anastasios^Aff6; Papapostolou, Androniki^Aff2; Michelakis, Evangelos^Aff2; Georgiopoulou, Maria^Aff2; Myrodia, Dimitra-Melia^Aff1; Tsiamalos, Panteleimon^Aff5; Syrigos, Konstantinos^Aff1; Chrysos, George^Aff5; Nitsotolis, Thomas^Aff1; Milionis, Haralampos^Aff4; Poulakou, Garyphallia^Aff1; Giamarellos-Bourboulis, Evangelos J.^{Aff2, IDs40121021005058_cor31}
Source:	Infectious Diseases and Therapy. :1-19
Database:	Springer Nature Journals